Vimta Labs Ltd share price logo

Vimta Labs Share Price (VIMTALABS)

Check the latest share price of Vimta Labs, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹939.21.18%

as on 04:01PM, 06 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Vimta Labs Stock Performance

Get live Vimta Labs share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹931.5
    Day's Price Range
    ₹958.05
  • 52 Week's Low

    52 Week's High

    ₹420
    52-Week Price Range
    ₹1,178
1 Month Return-3.55 %
3 Month Return-2.07 %
1 Year Return+ 92.89 %
3 Year Return+ 186.12 %
5 Year Return+ 1069.61 %
Previous Close₹950.40
Open₹950.40
Volume62.81K
Upper Circuit₹1,140.45
Lower Circuit₹760.35

Vimta Labs Fundamentals & Key Indicators

Check Vimta Labs market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹2,089.98 Cr

Return on Equity (ROE)

19.44

PE Ratio (TTM)

33.97

Return on capital employed (ROCE)

24.14

Industry PE ratio

102.22

Beta (LTM)

1.04

P/B Ratio

5.87

Dividend Yield

0

PEG Ratio

3.42

Quarterly Earnings Growth YOY

112.24

EPS (TTM)

18.5

Sector

Healthcare

Book Value

144.2

Technical Analysis

How to invest in Vimta Labs?

Investing in Vimta Labs is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Vimta Labs or VIMTALABS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Vimta Labs or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Vimta Labs with just a few clicks!

Vimta Labs Stock's Interest Amongst Investors

-54%

Period Jun 07, 2025 to May 08, 2025. Change in 30 Days vs previous period

Search interest for Vimta Labs Ltd Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Vimta Labs Valuation

Track how Vimta Labs P/E has moved over time to understand its valuation trends.

Vimta Labs in the last 5 years

  • Overview

  • Trends

Lowest (13.76x)

March 20, 2023

Today (33.97x)

June 6, 2025

Industry (102.22x)

June 6, 2025

Highest (46.83x)

December 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 33.97x

Vimta Labs Financial Results

Get the annual and quarterly financial summary of Vimta Labs, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25
Revenue

(in ₹ Cr)

75 (0%)80 (7%)75 (6%)85 (13%)90 (6%)
Net Income

(in ₹ Cr)

10 (0%)12 (22%)12 (1%)15 (24%)22 (41%)
Net Profit Margin13.58% (0%)15.50% (14%)16.40% (6%)18.00% (10%)23.91% (33%)
Value in ₹ crore
DetailsFY22FY23FY24FY25
Total Assets

(in ₹ Cr)

309 (0%)362 (17%)394 (9%)467 (18%)
Total Liabilities

(in ₹ Cr)

75 (0%)81 (8%)80 (1%)88 (10%)
Value in ₹ crore
DetailsFY21FY22FY23FY24FY25
Operating Cash Flow

(in ₹ Cr)

37 (0%)59 (59%)87 (47%)61 (30%)95 (55%)

Indices Featuring Vimta Labs Stock

Check stock indices that include Vimta Labs.

BSE Healthcare

₹43,222.41

0.4 (172.14%)

BSE Small-Cap

₹53,440.26

0.43 (229.82%)

Vimta Labs Earnings and Dividends

View detailed summary of the earnings and dividend history of Vimta Labs.

  • Vimta Labs Ltd Earnings Results

    Vimta Labs Ltd’s net profit jumped 112.24% since last year same period to ₹21.50Cr in the Q3 2024-2025. On a quarterly growth basis, Vimta Labs Ltd has generated 40.98% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Vimta Labs Ltd Dividends April,2025

    In the quarter ending March 2025, Vimta Labs Ltd has declared dividend of ₹2 - translating a dividend yield of 0.43%.

    Read More about Dividends

Vimta Labs Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Vimta Labs.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
36.7%
0.00
Foreign Institutions
3.66%
0.00
Mutual Funds
0%
0.00
Retail Investors
58.2%
0.00
Others
1.43%
0.00

Vimta Labs vs Peers

Compare market cap, revenue, PE, and other key metrics of Vimta Labs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA2,089.98213.92%0.54NANA
NA129.44-17.06%0.50NANA
NA147.5737.81%0.51NANA
NA28.63-16.5%0.58NANA
BUY1,966.77-10.97%0.00NANA

Vimta Labs News & Key Events

Latest news and events in one place to help you make informed investing decisions in Vimta Labs.

  • Vimta Labs Declares Dividend and Bonus Issue - 27 May, 2025

    Vimta Labs announced a Rs 2 dividend and its first-ever 1:1 bonus issue, subject to shareholder approval. The stock has shown significant long-term gains despite recent declines.
  • Vimta Labs Allocates Shares Under ESOP - 23 May, 2025

    On May 23, 2025, Vimta Labs allotted 18,272 equity shares under its Employee Stock Option Plan (ESOP), increasing its paid-up share capital to Rs. 4,45,05,568.
  • Vimta Labs Reports Strong Q4 Earnings and Expansion - 28 Apr, 2025

    Vimta Labs reported a 31% YoY profit increase for Q4 FY25, announced a 1:1 bonus issue, and plans to enter Biologics Contract R&D with Rs 50 crore investment.

Insights on Vimta Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 75.57 Cr → 95.13 Cr (in ₹), with an average increase of 10.9% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 12.28 Cr → 21.5 Cr (in ₹), with an average increase of 24.3% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, VIMTALABS stock has moved up by 92.9%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, VIMTALABS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, VIMTALABS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 58.27% to 58.20% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 36.76% to 36.70% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 3.81% to 3.66% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 0.13% to 0.00% in Mar 2025 quarter

About Vimta Labs

Vimta Labs Ltd., founded in 1984, is India's premier contract research and testing organization. They provide a wide range of services to several different industries such as pharmaceutical, biopharmaceutical, food, consumer goods, electronic-electrical, agrochemical, healthcare, medical devices and many others. These services range from drug discovery development, preclinical research, GLP and nonGLP clinical research, cGMP and non-GMP analytical services, preclinical research and testing for medical device companies, contract research and testing for agroscience companies, food testing and analytical development services, clinical diagnostics services, environmental regulatory services and more. Vimta was awarded ISO 9002 certification in 1994 and entered a joint venture in 1997 with ROSTEST Moscow, making an investment of 24 of the total Paidup Capital. In 2002, the Company began offering clinical diagnostics services. In 2020, Vimta acquired 100 Equity Shares of Emtac Laboratories Private Limited, making Emtac a wholly owned subsidiary of the Company. With a goal of expanding operations, they are in the process of constructing a five-times-larger facility in S.P.Biotech Park Genome Valley Hyderabad. By providing comprehensive services, certification and joint ventures, Vimta Labs Ltd. has become India's leading contract research and testing organization.

Revenue: ₹89.92Cr as on December 2024 (Q3 FY25)
Net Profit: ₹21.50Cr as on December 2024 (Q3 FY25)
Listing date: 15 Dec, 2005
Chairperson Name: S P Vasireddi
OrganisationVimta Labs Ltd
IndustryHealthcare
CEOS P Vasireddi
E-voting on sharesClick here to vote

Mutual Funds that own Vimta Labs

Check out the Mutual Funds with significant holdings in Vimta Labs.

FAQs

What is Vimta Labs share price today?

Vimta Labs share price today stands at ₹939.2, Open: ₹950.4, Previous Close: ₹950.4, High: ₹958.05, Low: ₹931.5, 52 Week High: ₹1178, 52 Week Low: ₹420.

What is today's traded volume of Vimta Labs?

Today's traded volume of Vimta Labs is 62.81K. Which means that 62.81K shares of Vimta Labs were bought and sold on the stock market during today's trading session.

What is Vimta Labs's market cap today?

Today's market capitalisation of Vimta Labs is ₹2,089.98 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Vimta Labs?

Vimta Labs’s 52 week high is ₹1178 and 52 week low is ₹420. The current share price of Vimta Labs is ₹939.2, which is -20.27% down from its 52 week high and 123.62% up from its 52 week low.